TY - JOUR
T1 - Sequelae and other conditions in Ebola virus disease survivors, Sierra Leone, 2015
AU - Mohammed, Hamish
AU - Vandy, Alren O.
AU - Stretch, Rebecca
AU - Otieno, David
AU - Prajapati, Mukesh
AU - Calderon, Mauricio
AU - Vandi, Mohamed
N1 - Publisher Copyright:
© 2017, Centers for Disease Control and Prevention (CDC). All rights reserved.
PY - 2017/1
Y1 - 2017/1
N2 - We rapidly assessed the health of Ebola virus disease (EVD) survivors in Kenema, Sierra Leone, by reviewing medical charts of all patients attending the Survivor Clinic of Kenema Government Hospital. Data were abstracted on signs and symptoms at every attendance. As of November 2015, a total of 621 attendances by 115 survivors with laboratory-confirmed EVD were made to the Survivor Clinic. Most (60.9%) survivors were women. Survivors’ median age was 28 years (range 0.25-70 years). Survivors attended the clinic a median of 5 times (range 1-21 times) each, and the median time from EVD discharge to attendance was 261 days (range 4-504 days). The most commonly reported signs and symptoms among the 621 attendances were headache (63.1%), fever (61.7%), and myalgia (43.3%). Because health needs of EVD survivors are complex, rapid chart reviews at survivor clinics should be repeated regularly to assess the extent of illness and prioritize service delivery.
AB - We rapidly assessed the health of Ebola virus disease (EVD) survivors in Kenema, Sierra Leone, by reviewing medical charts of all patients attending the Survivor Clinic of Kenema Government Hospital. Data were abstracted on signs and symptoms at every attendance. As of November 2015, a total of 621 attendances by 115 survivors with laboratory-confirmed EVD were made to the Survivor Clinic. Most (60.9%) survivors were women. Survivors’ median age was 28 years (range 0.25-70 years). Survivors attended the clinic a median of 5 times (range 1-21 times) each, and the median time from EVD discharge to attendance was 261 days (range 4-504 days). The most commonly reported signs and symptoms among the 621 attendances were headache (63.1%), fever (61.7%), and myalgia (43.3%). Because health needs of EVD survivors are complex, rapid chart reviews at survivor clinics should be repeated regularly to assess the extent of illness and prioritize service delivery.
UR - http://www.scopus.com/inward/record.url?scp=85006375378&partnerID=8YFLogxK
U2 - 10.3201/eid2301.160631
DO - 10.3201/eid2301.160631
M3 - Article
C2 - 27983503
AN - SCOPUS:85006375378
SN - 1080-6040
VL - 23
SP - 66
EP - 73
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 1
ER -
